Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Aveir Leadless Pacemaker Japan PMS

NCT: NCT07106788 · RECRUITING

NCT IDNCT07106788
StatusRECRUITING
Start Date2025-05-26
Completion2029-11

Brief Summary

The primary purpose of the PMS is to collect safety information on the Aveir DR leadless cardiac pacemaker (LP) system in a population indicated for de novo dual-chamber pacing. Additionally, the PMS will collect data on rollover patients from the Aveir DR i2i IDE, Aveir AR LP in patients indicated for single-chamber pacing in the right atrium, and upgradeability in patients implanted with single-chamber Aveir atrial or ventricular LP that require an upgrade to a dual-chamber Aveir LP.

Frequently Asked Questions

What is Aveir Leadless Pacemaker Japan PMS?

Aveir Leadless Pacemaker Japan PMS is a clinical trial registered under NCT07106788. Current status: RECRUITING.

What is the status of NCT07106788?

The current status of NCT07106788 (Aveir Leadless Pacemaker Japan PMS) is: RECRUITING.

When did Aveir Leadless Pacemaker Japan PMS start?

Aveir Leadless Pacemaker Japan PMS started on 2025-05-26.

Related Devices

PMA P150033 Leadless pacemaker Medtronic, Inc.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑